Synergy CHC Corp. reported its financial results for the third quarter and the first nine months of 2025, revealing a total revenue of $8.01 million for the three months ending September 30, 2025, compared to $7.13 million for the same period in 2024. For the nine-month period, the company generated $24.32 million in revenue, a slight decrease from $24.56 million in the prior year. The decline in revenue was attributed to a lack of repeat sales from a significant customer in 2024 and a shift in product mix. Despite the revenue drop, gross profit increased to $5.68 million for the quarter, representing a gross margin of 71%, up from 67% in the previous year.
The company’s net income for the third quarter was $125,327, a decrease from $783,593 in the same quarter of 2024. This decline was primarily due to increased interest expenses and the absence of other income that had positively impacted the previous year's results. For the nine-month period, net income rose to $2.47 million, compared to $2.02 million in 2024, bolstered by a $2.9 million license revenue from a new agreement. Operating expenses increased slightly, with selling and marketing expenses totaling $2.73 million for the quarter, up from $2.51 million in 2024, while general and administrative expenses rose to $1.64 million from $1.20 million.
In terms of operational developments, Synergy CHC Corp. has expanded its product offerings and market reach. The company launched a ready-to-drink beverage under its FOCUSfactor brand and is actively pursuing additional strategic acquisitions to enhance its portfolio. The company also established Synergy CHC Mexico in May 2025 to facilitate its expansion into the Mexican market. As of September 30, 2025, the company reported a total of 11.43 million shares issued, an increase from 8.72 million shares at the end of 2024, reflecting its efforts to raise capital through equity offerings.
The company’s balance sheet showed total assets of $20.69 million as of September 30, 2025, up from $16.34 million at the end of 2024. Current liabilities significantly decreased to $3.83 million from $17.18 million, primarily due to the repayment of short-term loans. Long-term liabilities increased to $25.11 million from $15.79 million, reflecting new debt incurred to support operations and growth initiatives. The company ended the quarter with $1.01 million in cash and cash equivalents, compared to $0.69 million at the end of 2024.
Looking ahead, Synergy CHC Corp. aims to continue its growth trajectory by expanding its product lines and entering new markets. The management is focused on leveraging its existing brands while exploring potential acquisitions that align with its strategic goals. The company remains optimistic about its future performance, despite the challenges posed by market conditions and competition in the consumer health care sector.
About Synergy CHC Corp.
Synergy CHC Corp. develops and markets consumer health, beauty, and lifestyle products, including the flagship FOCUSfactor brain health supplements and Flat Tummy wellness brands. Its business model relies on strategic acquisitions, retail partnerships, and an asset-light approach with third-party manufacturing. The company targets global markets through retail and direct-to-consumer channels, emphasizing product innovation, brand development, and consumer engagement in growing health and wellness categories.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.